BAM
KDNY

Bellevue Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bellevue Asset Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-27
Closed -$1.04K – 483
2023
Q2 		$1.04K Buy
+27
New +$1.04K ﹤0.01% 476